Search

Your search keyword '"A. Lortholary"' showing total 5,967 results

Search Constraints

Start Over You searched for: Author "A. Lortholary" Remove constraint Author: "A. Lortholary"
5,967 results on '"A. Lortholary"'

Search Results

1. Extrapulmonary Mycobacterium abscessus Infections, France, 2012-20201

3. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

4. Extrapulmonary Mycobacterium abscessus Infections, France, 2012–2020

5. Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France

6. Effectiveness, Safety, and Patterns of Real-World Isavuconazole Use in Europe (2015–2019)

7. The CD47/TSP-1 axis: a promising avenue for ovarian cancer treatment and biomarker research

8. Case report: Candida blankii osteo-articular infection in a patient with Chronic Granulomatous Disease

10. Deciphering Unexpected Vascular Locations of Scedosporium spp. and Lomentospora prolificans Fungal Infections, France

11. Fungal biomarkers in HIV-associated disseminated histoplasmosis: a multicenter diagnostic accuracy study on the Guiana shield

12. Characterization of patients with clonal mast cells in the bone marrow with clinical significance not otherwise specifiedResearch in context

13. Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP)

14. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programmeResearch in context

15. Characteristics and outcomes associated with CD2 and CD25 expression on bone marrow mast cells in patients with systemic mastocytosis

16. Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis

17. Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study

19. ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer

21. Epidemiology and prognostic factors of mucormycosis in France (2012–2022): a cross-sectional study nested in a prospective surveillance programme

23. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM

24. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

25. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from FranceResearch in context

26. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

28. Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation

29. Immunovirological status in people with perinatal and adult-acquired HIV-1 infection: a multi-cohort analysis from France

30. When to change treatment of acute invasive aspergillosis: an expert viewpoint

31. Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study

32. Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France

34. Refractory microascus bronchopulmonary infection treated with olorofim, france

35. Successful rescue TNF-α blocking for Mycobacterium genavense – Related immune reconstitution inflammatory syndrome: A case report

36. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network

37. Refractory Microascus Bronchopulmonary Infection Treated with Olorofim, France

38. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

39. Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial

40. Performance of clinical metagenomics in France: a prospective observational study

41. Severe adult hemophagocytic lymphohistiocytosis (HLHa) correlates with HLH-related gene variants

42. Pathophysiologic implications of elevated prevalence of hereditary alpha-tryptasemia in all mastocytosis subtypes

43. Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France

44. Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network

46. Improving Diagnosis of Pulmonary Mucormycosis: Leads From a Contemporary National Study of 114 Cases

48. CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients

49. Formulation and Stability of a 1% Clarithromycin-Based Topical Skin Cream: A New Option to Treat Buruli Ulcers?

50. New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting

Catalog

Books, media, physical & digital resources